back-office Open An Account
partner-with-us Partner with Us
IPO Synopsis
Accretion Pharmaceuticals Ltd
Initial public offer of upto 29,46,000 equity shares of face value of Rs. 10/- each (the equity shares) of Accretion Pharmaceuticals Limited (the company or accretion or the issuer) at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores (public issue) out of which 1,47,600 equity shares of face value of Rs. 10 each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the market maker reservation portion). The public issue less market maker reservation portion i.e., issue of 27,98,400 equity shares of face value of Rs. 10 each, at an issue price ofRs. [*] per equity share for cash, aggregating upto Rs. [*] crores is herein after referred to as the net issue. The public issue and net issue will constitute 26.50% and 25.17% respectively of the post-issue paid-up equity share capital of our company. Price Band: Rs. 96 to Rs. 101 per equity share of the face value of Rs. 10 each. The floor price is 9.6 times of the face value of the equity shares and the cap price is 10.1 times of the face value of the equity shares. Bids can be made for a minimum of 1200 equity shares and in multiples of 1200 equity shares thereafter.
Issue
Opens On Closes On
14-May-25 16-May-25
Money Payable On
Application Allotment
96.00 0.00
Minimum Application for shares in Nos : 1200 Further Multiples of : 1200
Cr Lead Managers to the Issue
Project Cost (.Cr) 0.00 Jawa Capital Services Pvt Ltd
Project Financed through Current Offer (.Cr) 28.28  
Post Issue Equity Share Capital (.Cr) 11.12
Issue Price () 96.00
Projects
Capital expenditure towards purchase of new equipment/machineries, etc
Capital expenditure towards upgradation of existing mfg facility
Expenditure in connection with product registration in overseas market
Repayment/prepayment of certain borrowings availed by the company
Funding working capital requiremnts
General corporate purposes
Promoted By
Harshad Nanubhai Rathod
Vivek Ashok Kumar Patel
Mayur Popatlal Sojitra
Listing At
NSE - SME
Registrar to the Issue
No Data Available

Attention Investors: Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. || Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. || Pay 20% upfront margin of the transaction value to trade in cash market segment. || Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. || Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.|| KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.|| No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.